FDA approves BEI's next-generation HTA (health technology assessment) system:
This article was originally published in Clinica
Executive Summary
The US FDA has approved for sale a smaller, lighter and more transportable version of gynaecology company BEI Medical Systems' minimally invasive device for treating menorrhagia. The new system represents the next generation of the firm's Hydro ThermAblator (HTA) system, which was first approved in April 2001. It is especially suited for physicians' offices and same-day surgery centres, where space, storage and portability are primary concerns, says the Teterboro, New Jersey firm.